Cefalotin: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m Protected "Cefalotin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
|
Revision as of 19:05, 27 September 2011
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | IV |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | 65 to 80% |
Metabolism | Hepatic |
Elimination half-life | 30 minutes to 1 hour |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H16N2O6S2 |
Molar mass | 396.44 g/mol |
WikiDoc Resources for Cefalotin |
Articles |
---|
Most recent articles on Cefalotin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefalotin at Clinical Trials.gov Clinical Trials on Cefalotin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefalotin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefalotin Discussion groups on Cefalotin Directions to Hospitals Treating Cefalotin Risk calculators and risk factors for Cefalotin
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefalotin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Cefalotin (INN) (Template:PronEng) or cephalothin (USAN) (Template:IPA) is a first-generation cephalosporin antibiotic. It was the first cephalosporin marketed and continues to be widely used. It is an intravenously-administered agent with a similar antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cefalotin sodium is commonly marketed under the trade name Keflin (Lilly).
See also
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics